20.07.2017 • NewsDede WillamsPipelinerefinery

Commission Clears Ineos-BP Pipeline Deal

(c) James Jones Jr/Shutterstock
(c) James Jones Jr/Shutterstock

The European Commission has approved Ineos’ acquisition of  BP’s North Sea pipelines for   up to $250 million. The deal includes the Forties Pipeline System (FPS) that links 85 oil and gas assets to the UK mainland and to the Kinneil terminal in Grangemouth, Scotland, which is adjacent to the Ineos refinery and chemical complex.

Terms of the deal include an initial cash payment of $125 million and a seven-year earn-out arrangement potentially worth another $125 million. About 300 BP staff supporting the operations are to transfer to Ineos.

Altogether, the pipeline has capacity to transport 575,000 bbl/d of oil from the UK’s first major offshore oil field – built by BP and opened in 1975 – to the UK mainland. Around 20% of the throughput goes to feed Ineos’ Grangemouth refinery.

Ineos will own and operate the Kinneil terminal, a gas processing plant, the Dalmeny terminal, various sites in Aberdeen, Scotland, and the Forties Unity Platform, along with other associated infrastructure.

According to the Commission, the proposed acquisition would raise no competition concerns because of its limited competitive impact on the market.

“The North Sea continues to present new opportunities for Ineos,” its chairman, Jim Ratcliffe, said. He said the pipeline system is “a UK strategic asset that was originally designed to work together to feed the Grangemouth refinery and petrochemical facilities.”

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.